MarketCap
Facebook
X
TelegramAnnual report 2023
added 12-27-2025
MorphoSys AG P/CF Ratio 2011-2026 | MOR
Annual P/CF Ratio MorphoSys AG
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -0.654 | 102 | -55.6 | -96.7 | - | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 102 | -96.7 | -12.9 |
P/CF Ratio of other stocks in the Biotechnology industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K |  USA |
 |
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M |  Canada |
 |
Adagene
ADAG
|
-2.96 | $ 2.75 | -5.5 % | $ 155 M |  China |
 |
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | USA |
 |
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | USA |
 |
ANI Pharmaceuticals
ANIP
|
18.7 | $ 81.68 | -0.39 % | $ 1.58 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | USA |
 |
Amgen
AMGN
|
13.6 | $ 341.02 | -0.56 % | $ 183 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | USA |
 |
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M |  France |
 |
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | USA |
 |
Aytu BioScience
AYTU
|
-8.14 | $ 2.58 | 0.1 % | $ 16.2 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.18 | -2.45 % | $ 7.65 B |  Australia |
 |
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
-2.48 | - | 3.16 % | $ 1.9 M | USA |
 |
AVROBIO
AVRO
|
-0.891 | - | 1083.1 % | $ 745 M | USA |
 |
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | USA |
 |
Biogen
BIIB
|
6.73 | $ 178.15 | 1.15 % | $ 25.9 B | USA |
 |
Brickell Biotech
BBI
|
-2.62 | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | USA |
 |
Beam Therapeutics
BEAM
|
-7.21 | $ 28.26 | -3.52 % | $ 2.33 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
-17.6 | $ 225.58 | 0.73 % | $ 5 B |  Danmark |
 |
Athira Pharma
ATHA
|
-0.166 | - | - | $ 269 M | USA |
 |
Atreca
BCEL
|
-0.607 | - | -11.76 % | $ 5.79 M | USA |
 |
BioNTech SE
BNTX
|
70.7 | $ 114.21 | -2.2 % | $ 27.2 B |  Germany |
 |
Burford Capital Limited
BUR
|
11.6 | $ 9.74 | 0.88 % | $ 1.52 B | Britain |
 |
Arrowhead Pharmaceuticals
ARWR
|
34.8 | $ 70.17 | 1.52 % | $ 9.39 B | USA |
 |
CASI Pharmaceuticals
CASI
|
-40.6 | $ 1.0 | 1.5 % | $ 136 M | USA |
 |
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | USA |
 |
Catalyst Biosciences
CBIO
|
1.3 | $ 9.97 | -1.77 % | $ 656 M | USA |
 |
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
-0.323 | - | -9.72 % | $ 5.89 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
-14.6 | - | -15.15 % | $ 60.3 M | Britain |
 |
Berkeley Lights
BLI
|
-2.46 | - | -7.31 % | $ 87 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-413 | $ 4.05 | -1.22 % | $ 8.81 B |  Israel |
 |
Amneal Pharmaceuticals
AMRX
|
6.19 | $ 13.87 | -1.74 % | $ 4.29 B | USA |
 |
AIkido Pharma
AIKI
|
-1.3 | - | 1.93 % | $ 17.4 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
-4.42 | - | -74.18 % | $ 955 K | USA |
 |
Cerus Corporation
CERS
|
26.5 | $ 2.34 | 0.65 % | $ 432 M | USA |
 |
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-6.14 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
-0.723 | - | 4.14 % | $ 49.1 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | USA |
 |
Baudax Bio
BXRX
|
-0.028 | - | 0.59 % | $ 63 K | USA |